Nuveen’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Nuveen’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-43,182	Closed	-$114K	–	3451
2020 Q1	$114K	Buy	43,182 +19,074	+79%	+$31.3K	﹤0.01%	3056
2019 Q4	$28K	Sell	24,108 -37,098	-61%	-$59.3K	﹤0.01%	3152
2019 Q3	$105K	Buy	61,206 +37,098	+154%	+$113K	﹤0.01%	3164
2019 Q2	$114K	Buy	+24,108	New	+$135K	﹤0.01%	3214

Nuveen's NTGN Position: Q2 2020 in Review

Nuveen sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 43,182 shares — an estimated $114K sold.

Nuveen first reported a position in NTGN in Q2 2019 and held it in 4 quarters. The position peaked at $114K in Q1 2020. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

Nuveen reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Nuveen sold 43,182 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $114K.
Nuveen first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
Nuveen's Neon Therapeutics, Inc. Common Stock position peaked at $114K in Q1 2020.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.